- Home
- CSTL vs VKQ Comparison
CSTL vs VKQ Comparison
Compare CSTL & VKQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSTL
- VKQ
- Stock Information
- Founded
- CSTL 2007
- VKQ 1991
- Country
- CSTL United States
- VKQ United States
- Employees
- CSTL N/A
- VKQ N/A
- Industry
- CSTL Medical Specialities
- VKQ Trusts Except Educational Religious and Charitable
- Sector
- CSTL Health Care
- VKQ Finance
- Exchange
- CSTL Nasdaq
- VKQ Nasdaq
- Market Cap
- CSTL 471.5M
- VKQ 503.6M
- IPO Year
- CSTL 2019
- VKQ N/A
- Fundamental
- Price
- CSTL $19.36
- VKQ $9.20
- Analyst Decision
- CSTL Strong Buy
- VKQ
- Analyst Count
- CSTL 6
- VKQ 0
- Target Price
- CSTL $37.67
- VKQ N/A
- AVG Volume (30 Days)
- CSTL 554.7K
- VKQ 174.2K
- Earning Date
- CSTL 08-04-2025
- VKQ 01-01-0001
- Dividend Yield
- CSTL N/A
- VKQ 4.53%
- EPS Growth
- CSTL N/A
- VKQ N/A
- EPS
- CSTL N/A
- VKQ 0.02
- Revenue
- CSTL $346,269,000.00
- VKQ N/A
- Revenue This Year
- CSTL N/A
- VKQ N/A
- Revenue Next Year
- CSTL $1.62
- VKQ N/A
- P/E Ratio
- CSTL N/A
- VKQ $478.00
- Revenue Growth
- CSTL 20.40
- VKQ N/A
- 52 Week Low
- CSTL $14.59
- VKQ $7.94
- 52 Week High
- CSTL $35.84
- VKQ $9.99
- Technical
- Relative Strength Index (RSI)
- CSTL 58.66
- VKQ 57.15
- Support Level
- CSTL $18.81
- VKQ $8.94
- Resistance Level
- CSTL $21.33
- VKQ $9.29
- Average True Range (ATR)
- CSTL 0.92
- VKQ 0.07
- MACD
- CSTL 0.45
- VKQ 0.03
- Stochastic Oscillator
- CSTL 70.74
- VKQ 74.29
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.
About VKQ Invesco Municipal Trust
Invesco Municipal Trust is a diversified, closed-end management investment company. The company's investment objective is to provide a high level of current income exempt from federal income tax, consistent with the preservation of capital.